The government's response to the COVID-19 pandemic opened the people's eyes to the relentless power of pharmaceutical companies.
Government employees should disclose who is paying them royaltiesThe government’s response to the COVID-19 pandemic opened the people’s eyes to the relentless power of pharmaceutical companies.
Enter Sen. Rand Paul, a physician who recently put his foot down and said enough is enough. He introduced Senate Bill 3664, the Royalty Transparency Act, to stop the decision-makers who have a financial stake in the drug production and approval process from being able to continue to shield their royalty agreements and arrangements from the public’s view.
At a hearing with Dr. Anthony Fauci, who was then the director of the National Institute of Allergy and Infectious Diseases, Mr. Paul asked whether he had received royalty payments from drug companies. He replied, “I doubt it,” but CBS News had already documented that Dr. Fauci had made money from companies producing drugs to fight AIDS.
If the automobile industry regulators at the National Highway Traffic Safety Administration received undisclosed payments from automobile manufacturers to approve cars — or if defense contractors compensated the Department of Defense generals for approving new planes and missiles — the offending parties would never hear the end of it.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
House Republicans Use a Big Lie to Stand Up for Big PharmaRepublicans rely on the wrong data to try to justify repealing Biden’s Medicare drug negotiation plan.
Read more »
Biden, Sanders Took on 'Big Pharma' and Patients LostThe Democrats' assault on the drug industry will result in fewer cures, less access to state-of-the-art medicines, and more avoidable death and suffering.
Read more »
No, Big Pharma’s high prices don’t drive innovationSmaller pharmaceutical startups are the real driver of drug development.
Read more »
Biden touts inhaler price drops with Bernie Sanders: 'Finally, finally we beat big Pharma'Inhalers can be expensive, particularly for those without insurance.
Read more »
'Stakes Are Huge': Medicare Makes Opening Bids in Price Negotiations With Big PharmaJake Johnson is a senior editor and staff writer for Common Dreams.
Read more »
Congress’ first tech crackdown in years is a gift to Big TechMeta and Google stand ready to reap a TikTok ban’s rewards.
Read more »